A citation-based method for searching scientific literature

Brian Werstein, Jennifer Dunlap, Michael J Cascio, Robert S Ohgami, Guang Fan, Richard Press, Philipp W Raess. J Mol Diagn 2020
Times Cited: 5







List of co-cited articles
16 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Detection of clonal heterogeneity and targetable mutations in myeloid sarcoma by high-throughput sequencing.
Cedric Pastoret, Roch Houot, Francisco Llamas-Gutierrez, Marie-Laure Boulland, Tony Marchand, Patrick Tas, Beatrice Ly-Sunnaram, Virginie Gandemer, Thierry Lamy, Mikael Roussel,[...]. Leuk Lymphoma 2017
12
60

Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing.
Karl Kashofer, Max Gornicec, Karin Lind, Veronica Caraffini, Silvia Schauer, Christine Beham-Schmid, Albert Wölfler, Gerald Hoefler, Heinz Sill, Armin Zebisch. Leuk Lymphoma 2018
16
60

Chemokine/chemokine receptor interactions in extramedullary leukaemia of the skin in childhood AML: differential roles for CCR2, CCR5, CXCR4 and CXCR7.
Claudia M J M Faaij, Annemieke J Willemze, Tom Révész, Melania Balzarolo, Cornelis P Tensen, Manja Hoogeboom, Maarten H Vermeer, Elisabeth van Wering, Christian M Zwaan, Gertjan J L Kaspers,[...]. Pediatr Blood Cancer 2010
27
40

Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia.
Ling Ge, Fan Ye, Xinliang Mao, Jia Chen, Aining Sun, Xiaming Zhu, Huiying Qiu, Zhengming Jin, Miao Miao, Chengcheng Fu,[...]. Biol Blood Marrow Transplant 2014
36
40

Granulocytic sarcoma: 32 cases and review of the literature.
Semra Paydas, Suzan Zorludemir, Melek Ergin. Leuk Lymphoma 2006
175
40

Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients.
S A Pileri, S Ascani, M C Cox, C Campidelli, F Bacci, M Piccioli, P P Piccaluga, C Agostinelli, S Asioli, D Novero,[...]. Leukemia 2007
371
40

Azacitidine in the treatment of extramedullary relapse of AML after allogeneic hematopoietic cell transplantation.
A Antar, Z K Otrock, M Kharfan-Dabaja, Z Salem, S Aractingi, M Mohty, A Bazarbachi. Bone Marrow Transplant 2013
16
40

Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years.
Varinder Kaur, Arjun Swami, Daisy Alapat, Al Ola Abdallah, Pooja Motwani, Laura F Hutchins, Yogesh Jethava. Hematology 2018
15
40

Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008.
Chezi Ganzel, Judith Manola, Dan Douer, Jacob M Rowe, Hugo F Fernandez, Elisabeth M Paietta, Mark R Litzow, Ju-Whei Lee, Selina M Luger, Hillard M Lazarus,[...]. J Clin Oncol 2016
49
40

Presentation and outcomes among patients with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysis.
Maryam Movassaghian, Andrew M Brunner, Traci M Blonquist, Hossein Sadrzadeh, Ashmeet Bhatia, Ashley M Perry, Eyal C Attar, Philip C Amrein, Karen K Ballen, Donna S Neuberg,[...]. Leuk Lymphoma 2015
31
40

¹⁸F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia.
Friedrich Stölzel, Christoph Röllig, Jörgen Radke, Brigitte Mohr, Uwe Platzbecker, Martin Bornhäuser, Tobias Paulus, Gerhard Ehninger, Klaus Zöphel, Markus Schaich. Haematologica 2011
74
40

Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas.
B Falini, D Lenze, R Hasserjian, S Coupland, D Jaehne, C Soupir, A Liso, M P Martelli, N Bolli, F Bacci,[...]. Leukemia 2007
78
40

Durable complete remission after single agent decitabine in AML relapsing in extramedullary sites after allo-SCT.
S N Singh, Q Cao, I Gojo, A P Rapoport, G Akpek. Bone Marrow Transplant 2012
21
40

Myeloid sarcoma: extramedullary manifestation of myeloid disorders.
Cristina Campidelli, Claudio Agostinelli, Richard Stitson, Stefano A Pileri. Am J Clin Pathol 2009
128
40

RTK-RAS pathway mutation is enriched in myeloid sarcoma.
Mihong Choi, Yoon Kyung Jeon, Choong-Hyun Sun, Hong-Seok Yun, Junshik Hong, Dong-Yeop Shin, Inho Kim, Sung-Soo Yoon, Youngil Koh. Blood Cancer J 2018
7
40

FLT3 mutations in myeloid sarcoma.
M Ali Ansari-Lari, Ching-Fen Yang, Rima Tinawi-Aljundi, Lisa Cooper, Patricia Long, Robert H Allan, Michael J Borowitz, Karin D Berg, Kathleen M Murphy. Br J Haematol 2004
38
40


Isolated myelosarcoma is characterized by recurrent NFE2 mutations and concurrent preleukemic clones in the bone marrow.
Vladimir Lazarevic, Christina Orsmark-Pietras, Henrik Lilljebjörn, Louise Pettersson, Marianne Rissler, Anna Lübking, Mats Ehinger, Gunnar Juliusson, Thoas Fioretos. Blood 2018
9
20

Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation.
Michael Heuser, Razif Gabdoulline, Patrick Löffeld, Vera Dobbernack, Henriette Kreimeyer, Mira Pankratz, Madita Flintrop, Alessandro Liebich, Sabrina Klesse, Victoria Panagiota,[...]. Ann Hematol 2017
33
20

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.
David P Steensma, Rafael Bejar, Siddhartha Jaiswal, R Coleman Lindsley, Mikkael A Sekeres, Robert P Hasserjian, Benjamin L Ebert. Blood 2015
782
20

Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations.
Jonas Samuel Jutzi, Titiksha Basu, Maximilian Pellmann, Sandra Kaiser, Doris Steinemann, Mathijs A Sanders, Adil S A Hinai, Annelieke Zeilemaker, Sarolta Bojtine Kovacs, Christoph Koellerer,[...]. Blood 2019
7
20

Copy number alterations detected as clonal hematopoiesis of indeterminate potential.
Koichi Takahashi, Feng Wang, Hagop Kantarjian, Xingzhi Song, Keyur Patel, Sattva Neelapu, Curtis Gumbs, Latasha Little, Samantha Tippen, Rebecca Thornton,[...]. Blood Adv 2017
15
20

Granulocytic sarcoma in nonleukemic patients.
J M Meis, J J Butler, B M Osborne, J T Manning. Cancer 1986
375
20

Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML.
Felicitas Thol, Razif Gabdoulline, Alessandro Liebich, Piroska Klement, Johannes Schiller, Christian Kandziora, Lothar Hambach, Michael Stadler, Christian Koenecke, Madita Flintrop,[...]. Blood 2018
103
20

The minimal that kills: Why defining and targeting measurable residual disease is the "Sine Qua Non" for further progress in management of acute myeloid leukemia.
Jan Philipp Bewersdorf, Rory M Shallis, Prajwal C Boddu, Brent Wood, Jerald Radich, Stephanie Halene, Amer M Zeidan. Blood Rev 2020
9
20

Myeloid Sarcoma.
Mohamed Magdy, Nagla Abdel Karim, Ihab Eldessouki, Ola Gaber, Mohamed Rahouma, Mohamed Ghareeb. Oncol Res Treat 2019
21
20

Diagnosis of fusion genes using targeted RNA sequencing.
Erin E Heyer, Ira W Deveson, Danson Wooi, Christina I Selinger, Ruth J Lyons, Vanessa M Hayes, Sandra A O'Toole, Mandy L Ballinger, Devinder Gill, David M Thomas,[...]. Nat Commun 2019
48
20

Genomic aberrations in myeloid sarcoma without blood or bone marrow involvement: characterization of formalin-fixed paraffin-embedded samples by chromosomal microarrays.
M Kamran Mirza, Madina Sukhanova, Friedrich Stölzel, Kenan Onel, Richard A Larson, Wendy Stock, Gerhard Ehninger, Friederike Kuithan, Klaus Zöphel, Poluru Reddy,[...]. Leuk Res 2014
12
20

Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases.
R S Neiman, M Barcos, C Berard, H Bonner, R Mann, R E Rydell, J M Bennett. Cancer 1981
773
20


The effectiveness of radiotherapy for leukemia cutis.
Khaled Elsayad, Michael Oertel, Uwe Haverkamp, Hans Theodor Eich. J Cancer Res Clin Oncol 2017
11
20


Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia.
Apostolia-Maria Tsimberidou, Hagop M Kantarjian, Sijin Wen, Michael J Keating, Susan O'Brien, Mark Brandt, Sherry Pierce, Emil J Freireich, L Jeffrey Medeiros, Elihu Estey. Cancer 2008
122
20

Frequent loss of RAF kinase inhibitor protein expression in acute myeloid leukemia.
A Zebisch, A Wölfler, I Fried, O Wolf, K Lind, C Bodner, M Haller, A Drasche, D Pirkebner, D Matallanas,[...]. Leukemia 2012
28
20

Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia.
Hiroaki Shimizu, Takayuki Saitoh, Nahoko Hatsumi, Satoru Takada, Hiroshi Handa, Takahiro Jimbo, Toru Sakura, Shuichi Miyawaki, Yoshihisa Nojima. Leuk Res 2013
15
20

Severe acute GvHD following administration of ipilimumab for early relapse of AML after haploidentical stem cell transplantation.
F-X Gros, T Cazaubiel, E Forcade, N Lechevalier, T Leguay, V Servant, R Tabrizi, L Clement, P-Y Dumas, A Bidet,[...]. Bone Marrow Transplant 2017
3
33

Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.
Randy A Taplitz, Erin B Kennedy, Eric J Bow, Jennie Crews, Charise Gleason, Douglas K Hawley, Amelia A Langston, Loretta J Nastoupil, Michelle Rajotte, Kenneth Rolston,[...]. J Clin Oncol 2018
93
20

Prognostic factors of treatment outcomes in patients with granulocytic sarcoma.
Tsung-Yu Lan, Dong-Tsamn Lin, Hwei-Fang Tien, Rong-Sen Yang, Chih-Yu Chen, Karl Wu. Acta Haematol 2009
84
20

Immune Escape of Relapsed AML Cells after Allogeneic Transplantation.
Matthew J Christopher, Allegra A Petti, Michael P Rettig, Christopher A Miller, Ezhilarasi Chendamarai, Eric J Duncavage, Jeffery M Klco, Nicole M Helton, Michelle O'Laughlin, Catrina C Fronick,[...]. N Engl J Med 2018
115
20

5-Azacytidine and DLI can induce long-term remissions in AML patients relapsed after allograft.
J Steinmann, H Bertz, R Wäsch, R Marks, R Zeiser, L Bogatyreva, J Finke, M Lübbert. Bone Marrow Transplant 2015
49
20

Radiological and clinical patterns of myeloid sarcoma.
Hans-Jonas Meyer, Maximilian Beimler, Gudrun Borte, Wolfram Pönisch, Alexey Surov. Radiol Oncol 2019
3
33

Chromosome 11q23 abnormalities in leukaemia.
S A Ridge, L M Wiedemann. Leuk Lymphoma 1994
13
20



Use of Radiation in Extramedullary Leukemia/Chloroma: Guidelines From the International Lymphoma Radiation Oncology Group.
Richard L Bakst, Bouthaina Shbib Dabaja, Lena K Specht, Joachim Yahalom. Int J Radiat Oncol Biol Phys 2018
14
20

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.
Bruce D Cheson, John M Bennett, Kenneth J Kopecky, Thomas Büchner, Cheryl L Willman, Elihu H Estey, Charles A Schiffer, Hartmut Doehner, Martin S Tallman, T Andrew Lister,[...]. J Clin Oncol 2003
20

Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review.
J C Byrd, W J Edenfield, D J Shields, N A Dawson. J Clin Oncol 1995
462
20

Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes.
M Kitagawa, I Saito, T Kuwata, S Yoshida, S Yamaguchi, M Takahashi, T Tanizawa, R Kamiyama, K Hirokawa. Leukemia 1997
197
20

Granulocytic sarcoma of the spine: MRI and clinical review.
Jee Hyun Seok, Jeongmi Park, Sun Ki Kim, Jung Eun Choi, Choon-Choo Kim. AJR Am J Roentgenol 2010
27
20

Clinicopathologic features and responses to radiotherapy of myeloid sarcoma.
Wan-Yu Chen, Chun-Wei Wang, Chin-Hao Chang, Heng-Hsiu Liu, Keng-Hsueh Lan, Jih-Luh Tang, Hwei-Fang Tien, Sung-Hsin Kuo, Ann-Lii Cheng. Radiat Oncol 2013
18
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.